Lucia Cinque

Lucia Cinque has a diverse work experience spanning multiple industries and roles. Lucia is currently serving as the Chief Innovation Officer & Managing Director at Wörwag Pharma GmbH & Co. KG. Prior to this, they co-founded and served as a board member at WhiteLab Genomics (YC W22). Lucia also held the position of VP Product & Innovation at ENDODIAG from June 2018 to May 2021. Lucia contributed to the growth and development of Apricity as Digital Product Strategy & Management from December 2020 to April 2021. Lucia Cinque has also worked at Genomic Vision in various capacities, including Director Product & Innovation, Product Innovation & Marketing Leader, Intellectual Property & Intelligence Manager, and R&D Project Manager. Lucia started their career with a research traineeship at Philips Research High Tech Campus in the Health Care Department.

Lucia Cinque completed a Ph.D. in DNA Biophysics, Microfluidics, and DNA Repair at Ecole normale supérieure from 2007 to 2011. Before that, they obtained a Master of Science degree in Biomedical Engineering from Politecnico di Milano, which they pursued from 2004 to 2006. Prior to their time at Politecnico di Milano, they also completed a Master of Science degree in Biomedical Engineering at Polytechnique Montréal from 2004 to 2005.